Left Ventricular Hypertrophy: Clinical Trials

82 trials for Left Ventricular Hypertrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

46 completed, 14 unknown, 11 recruiting, 5 terminated. 18 Not applicable, 18 Phase 4, 7 Phase 3, 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable18Completed 10, Not yet recruiting 2, Recruiting 2, Active not recruiting 1, Suspended 1, Terminated 1, Unknown 1
Phase 418Completed 12, Terminated 2, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 37Completed 4, Unknown 2, Terminated 1
Early Phase 11Recruiting 1
Phase 21Completed 1

Follow Left Ventricular Hypertrophy: new trials by email Literature Review of Left Ventricular Hypertrophy trials Research Report on Left Ventricular Hypertrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular Hypertrophy
Cardiac amyloidosis screening during CIED implantation - Cardiac Amyloidosis, Left Ventricular Hypertrophy
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris2422026-09-012026-07-29
Can Exercise Electrocardiography Discriminate Hypertensive Heart Disease From Obstructive Coronary Artery Disease? A Multimodality Imaging Study
Obstructive Coronary Artery Disease, Left Ventricular Hypertrophy
RecruitingUniversity of Pisa302026-09-012026-09-29
Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)
Angiotensin Receptor Blocker (ARB) - Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy
Phase 4Not yet recruitingSeoul National University Hospital6322026-08-152026-07-29
AI-based Echocardiography for Detection of Cardiac Amyloidosis
AI-based echocardiogram - Cardiac Amyloidosis, Heart Failure With Preserved Ejection Fraction (HFPEF)
Not applicableNot yet recruitingGermans Trias i Pujol Hospital2002026-07-012026-06-12
Left Ventricular Hypertrophy in CKD Patients
transthoracic echocardiography - Left Ventricular Hypertrophy
Not yet recruitingSohag University1002026-01-152026-02-02
US Benchmarking Clinical Study
HFpEF - Heart Failure With Preserved Ejection Fraction, HFmrEF
RecruitingeMyosound SAS1502025-09-162025-10-20
Evaluation of Left Ventricular Ejection Fraction Using an Accelerated Cardiac Cine-MRI Sequence With Deep Learning-based Image Reconstructions
accelerated cardiac cine-MRI sequence - Left Ventricular Ejection Fraction, Cardiac Magnetic Resonance Imaging
Not applicableRecruitingCentre Hospitalier Universitaire, Amiens612025-08-052026-01-16
AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM), Left Ventricular Hypertrophy
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine150002025-01-012025-12-04
Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy
Customized discharge and expedited referral instructions - Left Ventricular Hypertrophy
Not applicableCompletedYale University1652023-10-152026-05-29
A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Chang Gung ECG Abnormality Detection Software - Long QT Syndrome, Sinus Bradycardia
UnknownChang Gung Memorial Hospital43062023-10-062024-01-11
Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy
Hypertrophic Cardiomyopathy, Left Ventricular Hypertrophy
UnknownQilu Hospital of Shandong University6272023-10-012023-12-13
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
Eplerenone, Chlorthalidone, Potassium - Hypertension, Left Ventricular Hypertrophy
Phase 4RecruitingBrigham and Women's Hospital752023-08-252026-04-06
Sodium Lowering Vascular Effects Trial
Sodium Reduction Intervention - Endothelial Dysfunction, Vascular Stiffness
Not applicableActive not recruitingTulane University2562023-01-252026-10-01
Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.
Determine the etiology of hypokinetic and hypertrophic heart disease on transthoracic echocardiography data alone - Hypertension Arterial, Hypokinetic
RecruitingHospices Civils de Lyon10002023-01-012023-07-13
Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults
Echocardiography - Left Ventricular Hypertrophy
UnknownFirst Hospital of China Medical University6602023-01-012023-02-10
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
Software - Heart Failure, Cardiomyopathy, Hypertrophic
CompletedProlaio822022-10-282024-10-24
SGLT2 Inhibition in Hemodialysis
Dapagliflozin 10 MG, Placebo - Kidney Failure, Hemodialysis
Phase 2CompletedMedical University of Vienna2202022-10-012026-03-03
Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University Hospital
Echo - Left Ventricular Hypertrophy, Chronic Kidney Diseases
UnknownAssiut University2002022-02-012022-02-22
Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
sacubitril/valsartan, Amlodipine - Hypertension, Left Ventricular Hypertrophy
Phase 4UnknownShanghai Jiao Tong University School of Medicine1202021-11-282023-04-12
Postnatal Steroids Effects on Cardiac Function in Extremely Preterm
Echocardiography (ECHO) and lung ultrasound (LUS) studies before and after Dexamethasone administration - Left Ventricular Hypertrophy
RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre212021-06-152025-06-17

Showing 20 of 82. Sign in to see all of them.

Narrower conditions

Hypertrophy, Left Ventricular (82)  ·  Hypertension (23)  ·  Heart Failure (9)  ·  Cardiomyopathy, Hypertrophic (8)  ·  Aortic Valve Stenosis (6)  ·  Amyloid Neuropathies, Familial (5)  ·  Hypertrophy (5)  ·  Kidney Failure, Chronic (5)  ·  Renal Insufficiency, Chronic (5)  ·  Fabry Disease (4)  ·  Cardiomyopathies (3)  ·  Myocardial Infarction (3)  ·  Renal Insufficiency (3)  ·  Arteriovenous Fistula (2)  ·  Cardiovascular Diseases (2)

Broader conditions

Heart Diseases (82)  ·  Pathological Conditions, Anatomical (82)  ·  Pathological Conditions, Signs and Symptoms (82)  ·  Cardiomegaly (81)  ·  Cardiovascular Diseases (80)  ·  Hypertrophy (77)  ·  Vascular Diseases (37)  ·  Nutritional and Metabolic Diseases (19)  ·  Female Urogenital Diseases (16)  ·  Female Urogenital Diseases and Pregnancy Complications (16)  ·  Male Urogenital Diseases (16)  ·  Metabolic Diseases (16)  ·  Pathologic Processes (16)  ·  Urogenital Diseases (16)  ·  Urologic Diseases (16)

Interventions

Losartan (4)  ·  Amlodipine (3)  ·  Blood Specimen Collection (3)  ·  Echocardiography (3)  ·  Allopurinol (2)  ·  Eplerenone (2)  ·  Valsartan (2)  ·  candesartan (2)  ·  dapagliflozin (2)  ·  Angiotensin Receptor Antagonists (1)  ·  Atenolol (1)  ·  Bendroflumethiazide (1)  ·  Blood Pressure Monitoring, Ambulatory (1)  ·  Chlorthalidone (1)  ·  Cholecalciferol (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (3)  ·  Unity Health Toronto (3)  ·  University of Dundee (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  AstraZeneca (2)  ·  Indiana University (2)  ·  Massachusetts General Hospital (2)  ·  Medical University of Vienna (2)  ·  Mustafa Kemal University (2)  ·  National Heart Centre Singapore (2)  ·  University of Aarhus (2)  ·  Wake Forest University Health Sciences (2)  ·  A. D. Struthers (1)  ·  AbbVie (prior sponsor, Abbott) (1)  ·  Assiut University (1)

Countries

United States (21)  ·  United Kingdom (7)  ·  Italy (6)  ·  Canada (5)  ·  China (5)  ·  Turkey (Türkiye) (5)  ·  Denmark (4)  ·  Austria (3)  ·  Belgium (3)  ·  France (3)  ·  Germany (3)  ·  South Korea (3)  ·  Taiwan (3)  ·  Australia (2)  ·  Czechia (2)

Top investigators

Andrew T Yan, MD (2)  ·  Peter Juhl-Olsen, M.D. (2)  ·  Ron Wald, MD (2)  ·  Alaleh Gheissari, M.D. (1)  ·  Allan D Struthers, BSc, MD, FRCP, FESC (1)  ·  Allan D Struthers, BSc, MD, FRCP, FESC, FRSE (1)  ·  Allan Struthers, MD, FRCP (1)  ·  Amal Kh Ahmed, MD (1)  ·  Andrea Pahor, MD (1)  ·  Andrew M South, MD MS (1)  ·  Andrew M South, MD, MS (1)  ·  Andrzej Tykarski, Prof (1)  ·  Ann Eldred, MD (1)

Results publications

PMID 10450601, PMID 10678860, PMID 10908222, PMID 10940788, PMID 11208620, PMID 11422885, PMID 16253719, PMID 16376782, PMID 17389264, PMID 17494787, PMID 17921053, PMID 1798888, PMID 18404673, PMID 18458174, PMID 18591942, PMID 19153263, PMID 19515473, PMID 19528362, PMID 19687350, PMID 20016520, PMID 20038754, PMID 20167684, PMID 20411620, PMID 21242674, PMID 21330484, PMID 21353251, PMID 21746765, PMID 22306782, PMID 22337679, PMID 22495466, PMID 22642740, PMID 22805550, PMID 22869821, PMID 23194491, PMID 23316326, PMID 23505057, PMID 23690312, PMID 24088306, PMID 24107724, PMID 24173271, PMID 24398888, PMID 25545400, PMID 25803389, PMID 26208670, PMID 26356834, PMID 26386732, PMID 26394828, PMID 26437603, PMID 26439537, PMID 26546060

NIH funding

R01DK062030 (2), 2008 (1), 2014 (1), 2016 (1), K23HL148394 (1)